Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis‐Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the <scp>INFINITY</scp> Cohort
Tomomi Matsuoka(Nihon University), Hiroki Kobayashi(Nihon University), Masanori Abe(Nihon University), Akiko Tsunemi(Nihon University), Tetsuo Tagami(Seigakuin University), Hyoe Tomita(Koujin Hospital), Chinami Nagura(Saitama Prefecture), Yoshihiro Nakamura(Nihon University), Noriaki Maruyama(JR Tokyo General Hospital), Takashi Maruyama(Tohoku University)
Cited by 1
Related Papers
Testing the Feasibility and Usability of a Novel Smartphone-Based Self-Management Support System for Dialysis Patients: A Pilot Study
|JMIR Research Protocols|2017|50
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction
|International Journal of Molecular Sciences|2024|32
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model
|PLoS ONE|2014|31
Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose
|Frontiers in Immunology|2023|16
Free fatty acids support oligodendrocyte survival in a mouse model of amyotrophic lateral sclerosis
|Frontiers in Cellular Neuroscience|2023|8